Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
76
PPIH Quote, Financials, Valuation and Earnings
Last price:
$32.29
Seasonality move
:
4.49%
Day range:
$31.43 - $32.25
52-week range:
$8.81 - $36.48
Dividend yield:
0%
P/E ratio:
18.65x
P/S ratio:
1.29x
P/B ratio:
3.00x
Volume:
94.8K
Avg. volume:
105.3K
1-year change:
120.36%
Market cap:
$257.6M
Revenue:
$158.4M
EPS (TTM):
$1.71
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $84.7M | $138.6M | $142.6M | $150.7M | $158.4M | |
| Revenue Growth (YoY) | -33.66% | 63.59% | 2.9% | 5.68% | 5.12% | |
| Cost of Revenues | $73.5M | $106M | $104.3M | $109.2M | $105.1M | |
| Gross Profit | $11.2M | $32.5M | $38.3M | $41.5M | $53.2M | |
| Gross Profit Margin | 13.2% | 23.48% | 26.87% | 27.52% | 33.62% | |
| R&D Expenses | $300K | $400K | $700K | $500K | $100K | |
| Selling, General & Admin | $22.6M | $24.4M | $27.2M | $28.1M | $32.9M | |
| Other Inc / (Exp) | $4M | $1M | $533K | -$1.2M | $107K | |
| Operating Expenses | $22.6M | $24.5M | $27.2M | $28.2M | $32.9M | |
| Operating Income | -$11.5M | $8M | $11.1M | $13.3M | $20.3M | |
| Net Interest Expenses | $649K | $918K | $2.2M | $2.3M | $1.9M | |
| EBT. Incl. Unusual Items | -$7.8M | $8.3M | $9.6M | $9.9M | $18.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$133K | $2.3M | $3.6M | -$3.3M | $5.4M | |
| Net Income to Company | -$7.6M | $6.1M | $5.9M | $13.2M | $13.1M | |
| Minority Interest in Earnings | -- | -- | -- | $2.7M | $4.1M | |
| Net Income to Common Excl Extra Items | -$7.6M | $6.1M | $5.9M | $13.2M | $13.1M | |
| Basic EPS (Cont. Ops) | -$0.94 | $0.75 | $0.75 | $1.31 | $1.13 | |
| Diluted EPS (Cont. Ops) | -$0.94 | $0.72 | $0.73 | $1.30 | $1.12 | |
| Weighted Average Basic Share | $8.1M | $8.1M | $8M | $8M | $8M | |
| Weighted Average Diluted Share | $8.1M | $8.4M | $8.1M | $8.1M | $8M | |
| EBITDA | -$6.5M | $12.6M | $15M | $17.1M | $23.9M | |
| EBIT | -$11.5M | $8M | $11.1M | $13.3M | $20.3M | |
| Revenue (Reported) | $84.7M | $138.6M | $142.6M | $150.7M | $158.4M | |
| Operating Income (Reported) | -$11.5M | $8M | $11.1M | $13.3M | $20.3M | |
| Operating Income (Adjusted) | -$11.5M | $8M | $11.1M | $13.3M | $20.3M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $35.2M | $37.9M | $45.7M | $41.6M | $61.1M | |
| Revenue Growth (YoY) | 73.45% | 7.68% | 20.55% | -9.03% | 47.12% | |
| Cost of Revenues | $27.6M | $26.8M | $32.5M | $27.5M | $40.1M | |
| Gross Profit | $7.6M | $11.1M | $13.2M | $14.1M | $21M | |
| Gross Profit Margin | 21.67% | 29.36% | 28.86% | 33.89% | 34.35% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.9M | $6.6M | $7.1M | $8.5M | $9.6M | |
| Other Inc / (Exp) | $98K | -$948K | -$502K | -$50K | -- | |
| Operating Expenses | $6M | $6.6M | $7.2M | $8.5M | $9.6M | |
| Operating Income | $1.7M | $4.5M | $6M | $5.6M | $11.4M | |
| Net Interest Expenses | $270K | $717K | $640K | $468K | $497K | |
| EBT. Incl. Unusual Items | $1.5M | $2.9M | $4.9M | $5.1M | $10.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1M | $1.1M | $1.5M | $1.6M | $3M | |
| Net Income to Company | $495K | $1.7M | $3.4M | $3.5M | $7.9M | |
| Minority Interest in Earnings | -- | -- | $1.4M | $962K | $1.6M | |
| Net Income to Common Excl Extra Items | $495K | $1.7M | $3.4M | $3.5M | $7.9M | |
| Basic EPS (Cont. Ops) | $0.06 | $0.22 | $0.24 | $0.31 | $0.78 | |
| Diluted EPS (Cont. Ops) | $0.06 | $0.21 | $0.24 | $0.31 | $0.77 | |
| Weighted Average Basic Share | $8.1M | $8M | $8M | $8M | $8.1M | |
| Weighted Average Diluted Share | $8.4M | $8.1M | $8M | $8M | $8.2M | |
| EBITDA | $2.7M | $5.4M | $7M | $6.6M | $12.4M | |
| EBIT | $1.7M | $4.5M | $6M | $5.6M | $11.4M | |
| Revenue (Reported) | $35.2M | $37.9M | $45.7M | $41.6M | $61.1M | |
| Operating Income (Reported) | $1.7M | $4.5M | $6M | $5.6M | $11.4M | |
| Operating Income (Adjusted) | $1.7M | $4.5M | $6M | $5.6M | $11.4M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $120.7M | $145.3M | $146.9M | $153.6M | $200.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $95.4M | $107.5M | $107.3M | $103.5M | $133.5M | |
| Gross Profit | $25.3M | $37.7M | $39.7M | $50.1M | $67.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $23.1M | $26.4M | $27.7M | $30.7M | $39.4M | |
| Other Inc / (Exp) | $1.3M | -$914K | $1.1M | -$1M | -- | |
| Operating Expenses | $23.2M | $26.5M | $27.8M | $30.7M | $39.4M | |
| Operating Income | $2.1M | $11.2M | $11.8M | $19.4M | $27.9M | |
| Net Interest Expenses | $716K | $1.7M | $2.3M | $2M | $1.8M | |
| EBT. Incl. Unusual Items | $2.8M | $8.7M | $10.8M | $16.4M | $26.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.3M | $3M | $4.1M | -$2.9M | $7.7M | |
| Net Income to Company | $530K | $5.7M | $6.6M | $19.3M | $18.6M | |
| Minority Interest in Earnings | -- | -- | $1.6M | $3.5M | $4.7M | |
| Net Income to Common Excl Extra Items | $530K | $5.7M | $6.6M | $19.3M | $18.6M | |
| Basic EPS (Cont. Ops) | $0.07 | $0.71 | $0.63 | $2.00 | $1.73 | |
| Diluted EPS (Cont. Ops) | $0.06 | $0.69 | $0.62 | $1.98 | $1.71 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $6.5M | $15.3M | $15.9M | $23.1M | $31.7M | |
| EBIT | $2.1M | $11.2M | $11.8M | $19.4M | $27.9M | |
| Revenue (Reported) | $120.7M | $145.3M | $146.9M | $153.6M | $200.8M | |
| Operating Income (Reported) | $2.1M | $11.2M | $11.8M | $19.4M | $27.9M | |
| Operating Income (Adjusted) | $2.1M | $11.2M | $11.8M | $19.4M | $27.9M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $99.4M | $106.1M | $110.5M | $113.4M | $155.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $76.5M | $78.1M | $81.1M | $75.3M | $103.6M | |
| Gross Profit | $22.9M | $28.1M | $29.4M | $38.1M | $52.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $18M | $20M | $20.6M | $23.2M | $29.7M | |
| Other Inc / (Exp) | $996K | -$961K | -$349K | -$155K | -$47K | |
| Operating Expenses | $18.1M | $20.1M | $20.7M | $23.2M | $29.7M | |
| Operating Income | $4.8M | $8M | $8.7M | $14.9M | $22.5M | |
| Net Interest Expenses | $716K | $1.6M | $1.8M | $1.5M | $1.3M | |
| EBT. Incl. Unusual Items | $5.1M | $5.5M | $6.7M | $13.2M | $21.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1M | $2.8M | $3.3M | $3.7M | $6.1M | |
| Net Income to Company | $3.1M | $2.7M | $3.4M | $9.5M | $15M | |
| Minority Interest in Earnings | -- | -- | $1.6M | $2.3M | $2.9M | |
| Net Income to Common Excl Extra Items | $3.1M | $2.7M | $3.4M | $9.5M | $15M | |
| Basic EPS (Cont. Ops) | $0.38 | $0.34 | $0.23 | $0.91 | $1.51 | |
| Diluted EPS (Cont. Ops) | $0.37 | $0.33 | $0.23 | $0.89 | $1.49 | |
| Weighted Average Basic Share | $24.4M | $23.9M | $24M | $23.8M | $24.1M | |
| Weighted Average Diluted Share | $24.9M | $24.3M | $24.2M | $24.2M | $24.4M | |
| EBITDA | $8M | $10.7M | $11.6M | $17.5M | $25.4M | |
| EBIT | $4.8M | $8M | $8.7M | $14.9M | $22.5M | |
| Revenue (Reported) | $99.4M | $106.1M | $110.5M | $113.4M | $155.8M | |
| Operating Income (Reported) | $4.8M | $8M | $8.7M | $14.9M | $22.5M | |
| Operating Income (Adjusted) | $4.8M | $8M | $8.7M | $14.9M | $22.5M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.4M | $9.8M | $6.8M | $7.2M | $17.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $29.2M | $49.4M | $56.8M | $66.3M | $65M | |
| Inventory | $12.2M | $13.8M | $14.7M | $15.5M | $16.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.9M | $5.4M | $7.4M | $9.7M | $10M | |
| Total Current Assets | $53.9M | $78.4M | $85.7M | $98.8M | $108.8M | |
| Property Plant And Equipment | $40.3M | $36M | $31M | $44.1M | $43.6M | |
| Long-Term Investments | $2.7M | $4.3M | $2.9M | $1.7M | $2.6M | |
| Goodwill | $2.3M | $2.3M | $2.2M | $2.2M | $2.1M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $5.4M | $5.9M | $3.3M | $2.7M | $4.2M | |
| Total Assets | $102.7M | $123.4M | $123M | $155.7M | $165.2M | |
| Accounts Payable | $10.4M | $13.6M | $14.8M | $25.3M | $23.7M | |
| Accrued Expenses | $2.6M | $4.6M | $5.5M | $9M | $6.7M | |
| Current Portion Of Long-Term Debt | $3.9M | $6.8M | $6.2M | $4.1M | $2.5M | |
| Current Portion Of Capital Lease Obligations | $1.4M | $1.5M | $912K | $914K | $1.1M | |
| Other Current Liabilities | $1.4M | $1.3M | -- | -- | -- | |
| Total Current Liabilities | $28.3M | $38.4M | $43.8M | $57.7M | $54.1M | |
| Long-Term Debt | $19.4M | $25.7M | $17.9M | $22.3M | $22.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $53.4M | $68.9M | $65.2M | $83.7M | $82.1M | |
| Common Stock | $82K | $82K | $80K | $80K | $80K | |
| Other Common Equity Adj | -$3.3M | -$3.1M | -$6.4M | -$5.6M | -$8.2M | |
| Common Equity | $49.3M | $54.5M | $57.8M | $65.7M | $72.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | $6.3M | $11M | |
| Total Equity | $49.3M | $54.5M | $57.8M | $72M | $83.1M | |
| Total Liabilities and Equity | $102.7M | $123.4M | $123M | $155.7M | $165.2M | |
| Cash and Short Terms | $8.4M | $9.8M | $6.8M | $7.2M | $17.1M | |
| Total Debt | $23.4M | $32.4M | $24.1M | $26.4M | $25.4M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.8M | $9.7M | $7.4M | $14.7M | $28.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $43.5M | $58.1M | $63.9M | $62.1M | $89.2M | |
| Inventory | $15.4M | $14.8M | $16.1M | $16M | $19.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5M | $6.8M | $7.3M | $11.6M | -- | |
| Total Current Assets | $75.7M | $89.4M | $94.7M | $104.4M | $151.6M | |
| Property Plant And Equipment | $37.1M | $30.3M | $42.2M | $43.1M | $54.3M | |
| Long-Term Investments | $3.4M | $2.5M | -- | -- | -- | |
| Goodwill | $2.4M | $2.2M | $2.2M | $2.1M | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $6.4M | $3.2M | $4.5M | $3.9M | -- | |
| Total Assets | $122.5M | $125.8M | $144.2M | $160.7M | $217M | |
| Accounts Payable | $16.2M | $14M | $26.1M | $20.8M | $32.3M | |
| Accrued Expenses | $3.8M | $4.6M | $3.1M | $6.6M | -- | |
| Current Portion Of Long-Term Debt | $4.8M | $7.2M | $7.1M | $3.7M | -- | |
| Current Portion Of Capital Lease Obligations | $1.4M | $1.1M | $920K | $1.1M | -- | |
| Other Current Liabilities | $1.6M | $2.6M | -- | -- | -- | |
| Total Current Liabilities | $37.4M | $47.5M | $57.5M | $53.8M | $86.3M | |
| Long-Term Debt | $26.3M | $20M | $22.2M | $22.6M | $23.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $70.1M | $71M | $83.1M | $80.6M | $117M | |
| Common Stock | $81K | $80K | $80K | $80K | $81K | |
| Other Common Equity Adj | -$3.4M | -$6M | -$8.6M | -$7.3M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $4.2M | $9M | $14.2M | |
| Total Equity | $52.4M | $54.8M | $61.1M | $80.2M | $100M | |
| Total Liabilities and Equity | $122.5M | $125.8M | $144.2M | $160.7M | $217M | |
| Cash and Short Terms | $11.8M | $9.7M | $7.4M | $14.7M | $28.7M | |
| Total Debt | $31.1M | $27.2M | $29.3M | $26.3M | $41M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.6M | $6.1M | $5.9M | $13.2M | $13.1M | |
| Depreciation & Amoritzation | $4.7M | $4.3M | $3.6M | $3.8M | $3.6M | |
| Stock-Based Compensation | $1M | $1.1M | $1M | $913K | $860K | |
| Change in Accounts Receivable | $1.1M | -$19.1M | -$3.6M | -$11.1M | $394K | |
| Change in Inventories | $2.4M | -$1.6M | -$1.5M | -$830K | -$1.8M | |
| Cash From Operations | $165K | -$2.6M | -$1.2M | $14.7M | $13.9M | |
| Capital Expenditures | $2M | $2.3M | $7M | $11.1M | $2.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2M | -$2.3M | -$6.4M | -$11.1M | -$2.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $40M | $32.7M | $96.9M | $155.7M | $76.3M | |
| Long-Term Debt Repaid | -$44M | -$24.3M | -$92.1M | -$157.6M | -$77.1M | |
| Repurchase of Common Stock | $191K | $2.2M | $275K | $942K | -- | |
| Other Financing Activities | -- | $58K | $42K | -$197K | $46K | |
| Cash From Financing | -$4.1M | $6.2M | $4.5M | -$3.3M | -$907K | |
| Beginning Cash (CF) | $8.4M | $9.8M | $6.8M | $7.2M | $17.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$6.3M | $1.4M | -$3M | $447K | $9.9M | |
| Ending Cash (CF) | $1.7M | $11.2M | $3.9M | $7.8M | $26.7M | |
| Levered Free Cash Flow | -$1.8M | -$4.8M | -$8.2M | $3.6M | $11.1M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $495K | $1.7M | $3.4M | $3.5M | $7.9M | |
| Depreciation & Amoritzation | $998K | $855K | $983K | $970K | $984K | |
| Stock-Based Compensation | $270K | $243K | $230K | $233K | $320K | |
| Change in Accounts Receivable | $8.1M | $1.5M | $1.5M | -$1M | -$10.8M | |
| Change in Inventories | -$820K | $1.2M | -$2.3M | -$161K | -$3.3M | |
| Cash From Operations | $5.2M | $6.1M | $4.1M | $5.2M | $17.3M | |
| Capital Expenditures | $1M | $1.2M | $1.4M | $322K | $4.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1M | -$1.2M | -$1.4M | -$322K | -$4.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $11M | $20M | $23.5M | $18.1M | -- | |
| Long-Term Debt Repaid | -$9.6M | -$22.9M | -$25.4M | -$19M | -- | |
| Repurchase of Common Stock | $241K | -$8K | $629K | -- | -- | |
| Other Financing Activities | -$7K | -$159K | -$21K | -$27K | -- | |
| Cash From Financing | $918K | -$3.1M | -$2.5M | -$896K | -$2.2M | |
| Beginning Cash (CF) | $11.8M | $9.7M | $7.4M | $14.7M | $28.7M | |
| Foreign Exchange Rate Adjustment | -$66K | $227K | -$60K | -$99K | -$234K | |
| Additions / Reductions | $5M | $2M | $81K | $3.8M | $9.9M | |
| Ending Cash (CF) | $16.7M | $12M | $7.4M | $18.5M | $38.4M | |
| Levered Free Cash Flow | $4.2M | $4.9M | $2.7M | $4.8M | $12.4M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $530K | $5.7M | $6.6M | $19.3M | $18.6M | |
| Depreciation & Amoritzation | $4.4M | $3.8M | $3.6M | $3.7M | $3.8M | |
| Stock-Based Compensation | $1.1M | $1M | $925K | $856K | $2.2M | |
| Change in Accounts Receivable | -$11.3M | -$12.3M | -$7.6M | $625K | -$27.2M | |
| Change in Inventories | -$3.2M | $78K | -$1.4M | -$374K | -$3.7M | |
| Cash From Operations | -$1.8M | -$7.6M | $11.5M | $14.7M | $22M | |
| Capital Expenditures | $2.3M | $3.5M | $11.9M | $5M | $9.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.2M | -$3.5M | -$11.5M | -$5M | -$9.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $26.3M | $72.6M | $154.6M | $92.9M | -- | |
| Long-Term Debt Repaid | -$17.3M | -$62.2M | -$155.2M | -$95.8M | -- | |
| Repurchase of Common Stock | $495K | $2M | $951K | $1K | -- | |
| Other Financing Activities | $41K | -$64K | -$27K | -$17K | -- | |
| Cash From Financing | $8.3M | $8.6M | -$1.9M | -$3.1M | $1.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4M | -$2M | -$2.3M | $7.3M | $13.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$4.1M | -$11.2M | -$467K | $9.7M | $12.3M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.1M | $2.7M | $3.4M | $9.5M | $15M | |
| Depreciation & Amoritzation | $3.3M | $2.8M | $2.8M | $2.7M | $2.9M | |
| Stock-Based Compensation | $818K | $763K | $686K | $629K | $2M | |
| Change in Accounts Receivable | -$11.2M | -$4.3M | -$8.3M | $3.4M | -$23.8M | |
| Change in Inventories | -$3.2M | -$1.5M | -$1.4M | -$970K | -$2.8M | |
| Cash From Operations | -$32K | -$5.1M | $7.6M | $7.6M | $16M | |
| Capital Expenditures | $2M | $3.2M | $8.2M | $2.1M | $8.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.9M | -$3.1M | -$8.2M | -$2.1M | -$8.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $22.8M | $62.8M | $120.5M | $57.6M | $21.3M | |
| Long-Term Debt Repaid | -$16.8M | -$54.8M | -$117.9M | -$56.1M | -$18.1M | |
| Repurchase of Common Stock | $496K | $265K | $941K | -- | -- | |
| Other Financing Activities | -$8K | -$130K | -$199K | -$19K | $2K | |
| Cash From Financing | $5.3M | $7.6M | $1.2M | $1.3M | $4.1M | |
| Beginning Cash (CF) | $28.1M | $25.3M | $24.5M | $34.7M | $67.6M | |
| Foreign Exchange Rate Adjustment | $69K | $563K | $1000 | $654K | -$144K | |
| Additions / Reductions | $3.4M | -$46K | $615K | $7.5M | $11.5M | |
| Ending Cash (CF) | $31.6M | $25.8M | $25.1M | $42.8M | $79M | |
| Levered Free Cash Flow | -$2M | -$8.3M | -$587K | $5.5M | $7.6M | |
Get PPIH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PPIH
Sector
P/E ratio
18.65x
19.91x
PEG ratio
0.03x
0.18x
P/B ratio
3.00x
1.76x
Price / LTM sales
1.29x
0.88x
Growth Metrics
PPIH
Sector
Revenue growth
47.12%
4.83%
Earnings growth
148.82%
5.46%
Revenue (5-year growth)
4.41%
4.22%
Earnings forecast
--
$0.34
Profitability
PPIH
Sector
Profitability FY 2024
$53.2M
$248.2M
Return on invested capital
14.57%
4.68%
Return on assets
10.21%
3.09%
Return on equity
20.86%
8.07%
Earnings Date
Last Earnings Date
Dec
12
Next Earnings Date
Apr
30
Estimated Next Earnings Date
Mar
13
Balance Sheet
PPIH
Sector
Total cash
$28.7M
$136.7M
Short term investments
--
$31.8M
Total assets
$165.2M
$1.4B
Long term debt
$41M
$49.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 64x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
80
BNR alert for Jan 16
Burning Rock Biotech Ltd. [BNR] is down 2.85% over the past day.
Buy
90
PEN alert for Jan 16
Penumbra, Inc. [PEN] is up 0.36% over the past day.
Buy
100
TLN alert for Jan 16
Talen Energy Corp. [TLN] is down 8.86% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
